Company Overview and News
VICTORIA, British Columbia, June 22, 2018 (GLOBE NEWSWIRE) -- Carmanah Technologies Corporation (TSX:CMH) (“Carmanah” or the “Corporation”) today announced the voting results from its annual general meeting held on June 22, 2018. The shareholders voted on and approved to set the number of directors of the Corporation at four, the election of the directors of the Corporation, and the reappointment of KPMG LLP, Chartered Professional Accountants as auditors of the Corporation.
NEW YORK, NY / ACCESSWIRE / June 13, 2018 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has initiated coverage on UGE International Ltd. (TSXV: UGE; OTCQB: UGEIF) with a Target Price of C$1.02. (US$0.78).
CMHXF CMH UG UGEIF
VICTORIA, British Columbia, May 10, 2018 (GLOBE NEWSWIRE) -- Carmanah Technologies Corporation (TSX:CMH) (“the Company” or “Carmanah”) today reported its first quarter financial results for the period ended March 31, 2018. Currency amounts are in U.S. dollars unless otherwise noted and are for Carmanah’s continuing operations which exclude the operating results from the Company’s Power Division segment which was divested by way of two separate transactions in 2017.
VICTORIA, British Columbia, May 03, 2018 (GLOBE NEWSWIRE) -- Carmanah Technologies Corporation (TSX:CMH) (“the Company” or “Carmanah”) will release its first quarter 2018 financial results on Thursday May 10th, 2018 after market close. Carmanah has scheduled a conference call for analysts at 6:00 am PST (9:00 am ET) on Friday May 11th, 2018. To access, dial 1.866.229.4144 (Canada toll free) or +1.888.
VICTORIA, British Columbia, May 02, 2018 (GLOBE NEWSWIRE) -- Carmanah Technologies Corporation (TSX:CMH) (“the Company” or “Carmanah”) today reported that its Telematics business unit has received a product purchase order valued at USD$2.2 million. This order, together with a previous order in the amount of USD$1.2 million, are being disclosed because they are expected to have a material impact on the Company’s Telematics business unit.
VICTORIA, British Columbia, March 23, 2018 (GLOBE NEWSWIRE) -- Carmanah Technologies Corporation (TSX:CMH) (“the Company” or “Carmanah”) today reported its fourth quarter and fiscal 2017 financial results for the periods ended December 31, 2017. Currency amounts are in U.S. dollars unless otherwise noted.
19h - Asif
History and Development Himax Taiwan, its predecessor, was incorporated on June 12, 2001 as a limited liability company under the laws of the ROC. On April 26, 2005, the company established Himax Technologies Limited, an exempted company with limited liability under the Cayman Islands Companies Law, as a holding company to hold the shares of Himax Taiwan in connection with its reorganization and share exchange. On October 14, 2005, Himax Taiwan became its wholly owned subsidiary through a share exchange consummated pursuant to the ROC Business Mergers and Acquisitions Law through which the company acquired all of the issued and outstanding shares of Himax Taiwan, and the company issued ordinary shares to the shareholders of Himax Taiwan. Shareholders of Himax Taiwan received one of its ordinary shares in exchange for one Himax Taiwan common share. The share exchange was unanimously approved by shareholders of Himax Taiwan on June 10, 2005 with no dissenting shareholders and by ...
2018-06-22 - Asif
Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...
2018-06-22 - Asif
Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...
Silicon Investor Message Boards
This table lists all message boards related to TSX:CMH / Carmanah Technologies Co on message board site Silicon Investor.
|Carmanah Technologies Corporation (TSX - CMH)||ICMH - ICM Telecommunications Inc.|
|ICMH ICM TELECOM||Clayton Homes CMH|
|MCMH - MDECHEM Inc - A Slick Company with a Slick Product|